Literature DB >> 18666322

Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.

Christian Hardt1, Thomas Berns, Wolfgang Treder, Franz-Ludwig Dumoulin.   

Abstract

AIM: To investigate risk factors for severe clostridium difficile associated diarrhoea (CDAD) in hospitalised patients.
METHODS: We analysed risk factors for severe CDAD (associated with systemic signs of hypovolemia) in 124 hospitalised patients by retrospective chart review.
RESULTS: Severe CDAD was present in 27 patients (22%). Statistical analysis showed a significant association with a higher 30-d mortality (33% vs 4%, P < 0.001) and a higher proportion of longer hospital stay exceeding 14 d (74% vs 52%, P = 0.048). Charlson co-morbidity score (OR 1.29 for 1 point increment, P < 0.05) and serum C-reactive protein at diagnosis (OR 1.15 for 10 mg/L increment, P < 0.001) were independent predictors of severe CDAD.
CONCLUSION: Patients with a severe level of co-morbidity and high serum C-reactive protein levels at the time of diagnosis should receive particular attention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666322      PMCID: PMC2731185          DOI: 10.3748/wjg.14.4338

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease.

Authors:  Saima Aslam; Daniel M Musher
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

2.  A case of toxic megacolon secondary to Clostridium difficile-associated diarrhea worsened after administration of an antimotility agent and molecular analysis of recovered isolates.

Authors:  Hideaki Kato; Haru Kato; Makoto Nakamura; Atsushi Nakamura
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  Diarrhoea associated with antibiotic use.

Authors:  Lynne V McFarland
Journal:  BMJ       Date:  2007-07-14

4.  Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay.

Authors:  Daniel M Musher; Atisha Manhas; Pranav Jain; Franziska Nuila; Amna Waqar; Nancy Logan; Bernard Marino; Edward A Graviss
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.

Authors:  Lorraine Kyne; Stavros Sougioultzis; Lynne V McFarland; Ciarán P Kelly
Journal:  Infect Control Hosp Epidemiol       Date:  2002-11       Impact factor: 3.254

7.  Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027.

Authors:  T I I van der Kooi; M Koningstein; A Lindemans; D W Notermans; E Kuijper; R van den Berg; H Boshuizen; P M G Filius; S van den Hof
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

Review 8.  Update on the changing epidemiology of Clostridium difficile-associated disease.

Authors:  Lynne V McFarland
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-01

9.  Severe Clostridium difficile colitis.

Authors:  M S Rubin; L E Bodenstein; K C Kent
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

10.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07
View more
  18 in total

1.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

2.  Clostridium difficile ribotype does not predict severe infection.

Authors:  Seth T Walk; Dejan Micic; Ruchika Jain; Eugene S Lo; Itishree Trivedi; Eugene W Liu; Luay M Almassalha; Sarah A Ewing; Cathrin Ring; Andrzej T Galecki; Mary A M Rogers; Laraine Washer; Duane W Newton; Preeti N Malani; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

3.  Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries.

Authors:  Christian Eckmann; Matthew Wasserman; Faisal Latif; Graeme Roberts; Axelle Beriot-Mathiot
Journal:  Eur J Health Econ       Date:  2013-10

Review 4.  [Clostridium difficile infections in geriatric patients].

Authors:  R Simmerlein; A Basta; M Gosch
Journal:  Z Gerontol Geriatr       Date:  2016-10-26       Impact factor: 1.281

5.  Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.

Authors:  Udayakumar Navaneethan; Preethi Gk Venkatesh; Bo Shen
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

6.  The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.

Authors:  C Fehér; E Múñez Rubio; P Merino Amador; A Delgado-Iribarren Garcia-Campero; M Salavert; E Merino; E Maseda Garrido; V Díaz-Brito; M J Álvarez; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-08       Impact factor: 3.267

7.  Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis.

Authors:  Yiting Li; Haifeng Cai; Daniel A Sussman; Jean Donet; Kevin Dholaria; Jiajia Yang; Ami Panara; Ryan Croteau; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2021-09-23       Impact factor: 3.487

Review 8.  Clostridium Difficile Infection from a Surgical Perspective.

Authors:  Andreas M Kaiser; Rachel Hogen; Liliana Bordeianou; Karim Alavi; Paul E Wise; Ranjan Sudan
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

9.  Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.

Authors:  Nagham Khanafer; Abdoulaye Touré; Cécile Chambrier; Martin Cour; Marie-Elisabeth Reverdy; Laurent Argaud; Philippe Vanhems
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Usual opioid dosing does not adversely affect the course of healthcare-associated Clostridioides difficile infection.

Authors:  Monica Chowdhry; Douglas Haden; Suzanne Kemper; Kristen Helmick; Muhammad Kawsara; Ashley Huggett; Andrea Stark; Ahmad Khan; Muhammad Shah; Mustafa Bhaty; Junaid Farooq; Shailendra Singh; Brittain McJunkin
Journal:  Pain Manag       Date:  2020-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.